Blog

109 Articles

Dr. Elizabeth Jaffee
Research
March 6, 2024 • 5 Min

Platform Trial Increases Efficiency in Studying Immunotherapy

Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.

Dr. Gulam Manji
Research
February 23, 2024 • 5 Min

Chemotherapy Plus Immunotherapy Trial Shows Promise

Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.

Laboratory at the NIH
News
February 14, 2024 • 3 Min

New FDA Approval Brings More Treatment Options in Metastatic Disease

The FDA has approved the use of liposomal irinotecan in the chemotherapy combination NALIRIFOX for metastatic pancreatic cancer.

Pancreatic cancer researcher Dr. Shubham Pant
Research
February 9, 2024 • 5 Min

New Vaccine Harnesses Power Of the Lymph Nodes

A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.

long-term survivor Davi D'Agostino
Survivor Stories
January 19, 2024 • 1 Min

Steely Strength to Keep Going

Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.

slide of pancreatic cancer
Research
January 5, 2024 • 2 Min

Treating High Blood Sugar in People With Pancreatic Cancer

A new clinical trial explores the effectiveness of the drug glipizide in controlling high blood sugar in pancreatic cancer patients.

researcher Herve Tiriac
Research
November 20, 2023 • 4 Min

Two-Drug Combo Targets KRAS and Fights Resistance

Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.

Lab worker working on immunotherapy
Clinical Trials
November 7, 2023 • 2 Min

A New Approach to Immunotherapy for Advanced Pancreatic Cancer

Will a new type of immunotherapy help prevent tumors from developing resistance to chemotherapy? Research is underway.

Dr. Anup Kasi
Chemotherapy
October 25, 2023 • 3 Min

Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer

With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.

Radiation Whole Abdomen
Research
September 21, 2023 • 2 Min

Testing the Addition of a New Drug to Radiation Therapy for Localized Pancreatic Cancer

In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.

Dr. Vinod Balachandran
Research
September 5, 2023 • 3 Min

Phase II mRNA Vaccine Trial Opens

The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.

pancreatic cancer patient Dan Grunfeld
Survivor Stories
August 30, 2023 • 4 Min

Lots and Lots of Research Leads to a Better Outcome

Dan Grunfeld put his experience as a chemist to good use as he researched pancreatic cancer treatments to find a clinical trial.

Cathleen Janosko
Survivor Stories
July 11, 2023 • 4 Min

Genetic Profiling Leads to a Clinical Trial

With treatment not working and nothing to lose, Cathleen Janosko did her research and got help finding a clinical trial to match her tumor’s mutation.

Dr. Vinod Balachandran
Research
June 6, 2023 • 3 Min

mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II

Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.

yellow orange lines against a black background
Research
May 26, 2023 • 2 Min

Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome

Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.